Searchable abstracts of presentations at key conferences in endocrinology

ea0011p2 | Bone | ECE2006

Does adrenal function influence bone status in primary hyperparathyroidism? Preliminary results in a large series of patients at the time of the diagnosis

Gianotti L , Tassone F , Pia A , Razzore P , Cesario F , Magro G , Borretta G

PTH has been reported to enhance steroid secretion in vitro from human adrenocortical cells and some reports indicate an increased cortisol secretion in patients with PHPT that normalizes after surgery. Thus, the possible stimulatory effect of PTH on cortisol secretion could contribute to the impairment of bone status in primary hyperparathyroidism (PHPT). The aim of this study was to evaluate the relationship between parameters of adrenal function, bone metabolism and ...

ea0073oc11.4 | Oral Communications 11: Adrenal and Cardiovascular Endocrinoloyg | ECE2021

The management of post-operative recurrences in patients with adrenocortical carcinoma (ACC): The experience of San Luigi Hospital

Calabrese Anna , Puglisi Soraya , Basile Vittoria , Perotti Paola , Berchialla Paola , Pia Anna , Reimondo Giuseppe , Terzolo Massimo

BackgroundThe management of post-operative recurrences of ACC remains controversial, although the current guidelines recommend a surgical approach whenever feasible with radical intent.AimThe aim of our study was to evaluate retrospectively the management of recurrences in patients with ACC. We collected data of 106 patients with ACC followed at the San Luigi Hospital for the management of recurrence. Median ...

ea0073aep827 | Late Breaking | ECE2021

Germline variants of the MEN1 gene in 132 subjects with clinical indication of genetic diagnosis, born in Argentina

Patricia Fainstein-Day , Lorena Viale Maria , Pia Serra Maria , Kozak Andrea

Multiple Endocrine Neoplasia type 1 (MEN1) is an autosomal dominant inherited disease with a high degree of penetrance. The three most common locations of tumors are the parathyroid glands, the gastro-duodenum pancreas and/or the anterior pituitary gland. The gene involved in this disease is MEN 1, a tumor suppressor gene located on chromosome 11q13. The objective of our work was to describe the genotype of patients with MEN 1 born in Argentina.Subjects ...

ea0099p25 | Adrenal and Cardiovascular Endocrinology | ECE2024

Prevalence and outcome of primary aldosteronism in PBMAH: A single center study and systematic review of the literature

Panarelli Annalisa , Nowak Elisabeth , Adam Pia , Schweizer Junia , Stuefchen Isabel , Zopp Stephanie , Reincke Martin

Context: Patients with primary bilateral macronodular adrenocortical hyperplasia (PBMAH) usually present with bilateral benign adrenocortical macronodules at imaging and variable levels of cortisol excess. There is anecdotal evidence that, besides cortisol, other adrenal steroids, like mineralocorticoids, can be oversecreted.Objective: To assess the prevalence, clinical, biochemical characteristics and imaging features of aldosterone excess leading to pr...

ea0081rc10.7 | Rapid Communications 10: Diabetes, Obesity, Metabolism and Nutrition 3 | ECE2022

Knowledge about Diabetic Ketoacidosis in Patients with Type 1 Diabetes mellitus – Data of a Patient-centered Questionnaire

Hepprich Matthias , Stiebitz Sebastian , Schultes Bernd , Schmitz Daniela , Felix Barbara , Rutishauser Jonas , Schubert Sabine , Roser Pia , Aberle Jens , Rudofsky Gottfried

Background/Introduction: Diabetic ketoacidosis (DKA) is a severe complication of diabetes mellitus type 1 (T1DM) with potentially life-threatening course. Data on patient knowledge about DKA in German-speaking countries is rare. Thus, we aimed to gather data about T1DM patients’ knowledge in terms of DKA.Methods: Together with two T1DM patients and an experienced diabetes counselor, we developed an anonymous questionnaire covering general knowledge ...

ea0063p26 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

How do sex and BMI affect glucocorticoid treatment in adrenal insufficiency?

Puglisi Soraya , Tabaro Isabella , Cannavo Salvatore , Borretta Giorgio , Pellegrino Micaela , Chiappo Francesca , Pia Anna , Terzolo Massimo , Reimondo Giuseppe

Background and objective: Optimization of glucocorticoid (GC) replacement therapy in adrenal insufficiency (AI) is crucial to avoid consequences of under- or overtreatment. Dosing of GC replacement is mainly based on clinical grounds; however, the impact of patient’s characteristics on daily GC requirement is poorly evaluated. The aim of the study is to assess the influence of sex (M/F) and BMI on dosing GC in patients with AI of different etiology....

ea0042p42 | (1) | Androgens2016

High levels of the AR-V7 splice variant and co-amplification of the Golgi protein coding YIPF6 in AR amplified prostate cancer bone metastases

Djusberg Erik , Jernberg Emma , Thysell Elin , Golovleva Irina , Lundberg Pia , Crnalic Sead , Widmark Anders , Bergh Anders , Brattsand Maria , Wikstrom Pernilla

The relation between androgen receptor (AR) gene amplification and other mechanisms behind castration-resistance in prostate cancer, such as increased expression of constitutively active AR variants and steroid-converting enzymes have been poorly examined. Specific aims of this study were to examine AR amplification in treatment-naïve and castration-resistant prostate cancer (CRPC) bone metastases and to explore molecular and functional differences. AR gene amplification ...

ea0041gp42 | Bone & Calcium Homeostasis (1) | ECE2016

Hypercalcemia in patients with lymphoma

Pia Marengo Agustina , Guerrero Perez Fernando , Mercadal Vilchez Santiago , Gonzalez Barca Eva Maria , Peiro Martinez Inmaculada , Villabona Artero Carles

Introduction: Calcitriol-mediated hypercalcemia is one of the most common paraneoplastic syndromes associated with lymphoma.Aim: Evaluate clinical and biochemical manifestations as well on the management of hypercalcemia in patients with lymphoma.Materials and methods: Prospective analysis of patients with lymphoma who developed hypercalcemia during September-2011 and January-2016.Results: Two hundred and six...

ea0041ep247 | Clinical case reports - Pituitary/Adrenal | ECE2016

Pituitary adenoma associated with pheochromocytoma/paraganglioma

Guerrero Fernando , Arcano Karina , Marengo Agustina Pia , Robledo Mercedes , Diez Juan Jose , Lisbona Arturo , Iglesias Pedro , Villabona Carles

Background: Pituitary adenomas (PA) and pheochromocytomas/paraganglioma (pheo/PGL) can occur in the same patient due to coincidence or of shared pathogenesis. There is evidence that, at least in some cases, classical pheo/PGL predisposing genes, may also play a role in pituitary tumorigenesis. A new condition called ‘the three P Association’ (3PAs) for the combination of PA with pheo/PGL has been recently described in patients with or without succinate dehydrogenase ...

ea0037oc12.4 | Pituitary – Clinical | ECE2015

The changing faces of corticotroph-cell adenomas: the role of proconvertase 1/3

Faustini-Fustini Marco , Righi Alberto , Asioli Sofia , Morandi Luca , Zoli Matteo , Mazzatenta Diego , Frank Giorgio , Foschini Maria Pia

Introduction: The possible change in the pattern of hormonal secretion by pituitary tumours is a very intriguing issue indeed, notably in the case of corticotroph-cell adenomas.Methods/design: We retrospectively reviewed the records of 1259 consecutive endoscopic endonasal surgical procedures for pituitary adenomas from 1998 to 2013. Of these, 132 were ACTH-secreting adenomas associated with Cushing’s disease (CD) and 44 were silent corticotroph-cel...